Baumgartner Robert V reported option exercise involving 15,940 shares of BIO-TECHNE Corp at $0.00 for $0 on Sep 22, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Sep 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
15,940Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
62,443Direct
Trade date
Sep 22, 2026Option exercise
Filed
Sep 24, 2026, 4:52 PM ET2-day reporting delay
Accession
0000914190-26-000139Code M · Transaction 229157
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 22, 2026Tax withholding5,559$72.55−$403,305.45Trade 229158
Sep 22, 2026Option exercise15,940$0.00$0Trade 229159
3 transaction rows in this filing. Joint filers share the same rows.

TECH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TECH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.1%1w ago −0.1%1d ago 0%
Returns since7d 0%30d +0.2%90d180d1y

Footnotes in full

F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.